Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study for Intravenous (IV) TKM-100802

Clinical trial NCT02041715 · TERMINATED

Trial details

NCT number: NCT02041715
Sponsor: Arbutus Biopharma Corporation
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Ebola Virus Infection

Start date: 2014-01-01
Primary completion: 2015-07-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.